Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Megumi Teramura"'
Autor:
Tomoaki Morioka, Yasuhisa Okuno, Shoko Tsuchikura, Masaaki Inaba, Eiko Lee, Katsuhito Mori, Hiroki Ueno, Masanori Emoto, Megumi Teramura, Hidenori Koyama, Kayo Shinohara, Yoshiki Nishizawa, Tetsuo Shoji
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 16:33-39
Aims: The clinical implications of stiffness of the carotid artery (CA) have not been fully clarified in the prediction of coronary artery disease (CAD), although intima-media thickness (IMT) has been established as a surrogate marker. We examined th
Autor:
Yoshiki Nishizawa, Takahiro Araki, Megumi Teramura, K. Motozuka, T. Tashiro, Hisayo Yokoyama, Masanori Emoto, Katsuhito Mori, K. Mochizuki, Yuichi Inoue
Publikováno v:
Diabetes, Obesity and Metabolism. 10:400-407
Whole-body glucose utilization consists of mitochondrial glucose oxidation and non-oxidative glycogen synthesis. We examined whether reduction of both non-oxidative glucose disposal and glucose oxidation contributes to insulin resistance in type 2 di
Autor:
Hidenori Koyama, Megumi Teramura, Masaaki Inaba, Eiko Lee, Katsuhito Mori, Yoshiki Nishizawa, Takahiro Araki, Masanori Emoto, Hisayo Yokoyama, Koka Motoyama, Tetsuo Shoji
Publikováno v:
Clinical Endocrinology. 66:246-250
Summary Objective Fetuin-A is a circulating glycoprotein which is well characterized as an inhibitor of ectopic calcification. Vascular calcification commonly found in chronic kidney disease (CKD) patients is a predictor of cardiovascular death. Rece
Autor:
Hisayo Yokoyama, Sawako Hatsuda, Takaaki Maeno, Masaaki Inaba, Megumi Teramura, Masanori Emoto, Takahiro Araki, Tetsuo Shoji, Yoshiki Nishizawa, Hidenori Koyama, Katsuhito Mori, Kayo Shinohara
Publikováno v:
Metabolism. 55:996-1001
Adiponectin, an adipocyte-specific plasma protein, has been reported to exhibit protective effects against atherosclerosis as well as an insulin-sensitizing effect. This study was designed to investigate the effect of adiponectin on carotid arterial
Autor:
Katsuhito Mori, Masaaki Inaba, Hisayo Yokoyama, Takahiro Araki, Tetsuo Shoji, Masanori Emoto, Hidenori Koyama, Megumi Teramura, Y. Nishizawa
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 91:290-294
Impaired nonoxidative glucose disposal and decrease in mitochondrial glucose oxidation both contribute to insulin resistance in diabetic subjects.In the present study, we investigated whether plasma adiponectin is associated with glucose oxidation an
Autor:
Tetsuo Shoji, Masaaki Inaba, Takahiro Araki, Eiko Lee, Katsuhito Mori, Megumi Teramura, Yoshiki Nishizawa, Hisayo Yokoyama, Hidenori Koyama, Masanori Emoto
Publikováno v:
Metabolism: clinical and experimental. 57(9)
Fetuin-A (alpha2-Heremans-Schmid glycoprotein), a circulating glycoprotein, can inhibit insulin signaling both in vivo and in vitro. Recently, we and another independent group have shown that fetuin-A is positively associated with insulin resistance
Autor:
Megumi Teramura, Tetsuo Shoji, Yoshiki Nishizawa, Takahiro Araki, Hisayo Yokoyama, Koka Motoyama, Katsuhito Mori, Masaaki Inaba, Masanori Emoto, Kayo Shinohara, Hidenori Koyama
Publikováno v:
Journal of atherosclerosis and thrombosis. 14(4)
en-abstract=Aim: The present study aimed to clarify the clinical impact of modified NCEP-ATP III criteria for metabolic syndrome (MS) and Framingham Risk Score (FRS) on carotid atherosclerosis in 615 Japanese adults (319 men and 296 women) including
Autor:
Takahiro Araki, Megumi Teramura, Tetsuo Shoji, Hisayo Yokoyama, Yoshiko Ikuno, Eiko Lee, Katsuhito Mori, Yoshiki Nishizawa, Masanori Emoto, Toshiaki Konishi, Hidenori Koyama, Koka Motoyama
Publikováno v:
Metabolism: clinical and experimental. 58(2)
The aims of the present study are to investigate the effect of glimepiride 1 mg/d on plasma adiponectin and to assess the contribution of adiponectin in changing high-density lipoprotein cholesterol (HDL-c) levels after glimepiride treatment. Forty p
Publikováno v:
Nihon Naika Gakkai Zasshi. 97:857-858
Autor:
Y. Nishizawa, Megumi Teramura, Tetsuo Shoji, Takahiro Araki, Masaaki Inaba, Masanori Emoto, Katsuhito Mori, Hidenori Koyama, Hisayo Yokoyama
Publikováno v:
Diabetes Care. 29:468-468
Fetuin-A (α2-Heremans Schmid glycoprotein) is a circulating glycoprotein that can inhibit insulin receptor autophosphorylation and subsequent downstream signaling in vitro (1, 2). Recently, it has been reported (3) that fetuin-A–deficient mice dem